Marco Rubio Criticizes WHO Ebola Response as United States Continues Major Public Health Funding Cuts

Marco Rubio has sharply criticized the World Health Organization over its handling of the escalating Ebola outbreak in the Democratic Republic of the Congo, as the United States continues sweeping reductions in federal public health spending and international aid programs.

Speaking during a policy briefing in Washington, Rubio questioned the WHO’s response speed and preparedness after Ebola cases linked to the Bundibugyo strain surged in eastern Congo. The outbreak has already resulted in at least 500 suspected infections and 130 suspected deaths, according to WHO figures released this week.

Rubio said international health agencies must be “fully accountable” during rapidly evolving disease emergencies and argued that reforms are needed to improve outbreak coordination and transparency.

Criticism Comes Amid US Health Spending Reductions

The criticism comes as President Donald Trump’s administration continues implementing extensive reductions to US public health and foreign assistance programs.

Recent budget actions have affected multiple agencies involved in global disease surveillance, pandemic preparedness, and international medical aid. Critics of the cuts have warned that reduced funding could weaken America’s ability to respond to global outbreaks and support emergency interventions abroad.

The administration has defended the reductions as part of a broader effort to streamline federal spending and shift more responsibility to international partners and regional governments.

WHO Evaluating Experimental Ebola Vaccines

The WHO has acknowledged growing concerns over the scale of the Ebola outbreak and is currently evaluating whether experimental vaccines and treatments under development could be deployed under emergency protocols.

The Bundibugyo strain differs from the more common Zaire strain of Ebola, for which approved vaccines already exist. Health officials said there are currently no fully licensed vaccines specifically targeting the Bundibugyo variant.

WHO Director-General Tedros Adhanom Ghebreyesus previously stated he was “deeply concerned” by the outbreak’s rapid spread and the increasing pressure on local healthcare systems in eastern Congo.

Public Health Experts Warn of Global Risks

Public health experts have cautioned that outbreaks in regions with fragile healthcare infrastructure can quickly escalate if international support weakens. Several global health specialists also warned that cuts to disease monitoring programs could affect early detection of emerging threats.

Humanitarian organizations operating in the region said insecurity, population displacement, and limited medical resources are already complicating containment efforts in affected communities.

Ebola is a highly infectious viral hemorrhagic disease transmitted through direct contact with infected bodily fluids or contaminated materials. Symptoms include fever, vomiting, bleeding, and organ failure, with fatality rates varying depending on the strain and treatment access.

International Response Continues

Despite political criticism and funding debates, international health agencies continue coordinating surveillance, treatment, and emergency response operations across affected regions of the DRC and neighboring countries.

No official announcement has yet been made regarding the timeline for deploying experimental vaccines or treatments in the current outbreak.